NCT01453478 A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced Status COMPLETED Phase PHASE1
NCT01453348 Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine Status COMPLETED Phase PHASE3
NCT01453296 Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects Status COMPLETED Phase PHASE2
NCT01453075 Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I) Status COMPLETED Phase PHASE1
NCT01453049 An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients Status TERMINATED Phase PHASE3
NCT01453023 Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study Status COMPLETED Phase PHASE2
NCT01450995 Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and Imitrex Status COMPLETED Phase PHASE4
NCT01449929 Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects Status COMPLETED Phase PHASE3
NCT01449812 Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine Status COMPLETED Phase PHASE3
NCT01449799 An Investigation of the Pharmacokinetics of GSK961081 and Fluticasone Propionate in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01449188 To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT01446237 U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne Status COMPLETED Phase NA
NCT01446224 Cardiovascular and Torsades de Pointes Monitoring for Pazopanib Status COMPLETED Phase N/A
NCT01445587 A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma Status WITHDRAWN Phase PHASE2
NCT01445301 Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects Status COMPLETED Phase PHASE3